Other studies demonstrated that cooperation between sortilin and TrkA facilitates the invasion of breast carcinoma by activating Akt and Src molecules via binding with the cancer-accessory factor of proNGF (35, 46). The gene discussed is AKT1; the disease is breast carcinoma.